...SVP of regulatory affairs. She was chief development officer and head of regulatory and quality at Partner Therapeutics Inc....

...has resigned as CEO and chairman and will transition to an advisory role. Edwin Rock joined cancer company Partner Therapeutics Inc....
...was president and CEO of Meditope Biosciences Inc. BC Staff Thrive Earlier Detection Corp. Black Diamond Therapeutics Inc. MorphoSys AG Partner Therapeutics Inc. Brii...

...ventilation (see “Second IL-6 Failure” ; “Data for IL-6 mAb in COVID-19 Disappoint” ). Separately, Partner Therapeutics Inc....
...stimulating factor (GM-CSF)) U.S. Biomedical Advanced Research and Development Authority U.S. Department of Defense Johnson & Johnson Regeneron Pharmaceuticals Inc. Sanofi Partner Therapeutics Inc. SARS-CoV-2...

...general counsel at NeoTract Inc. prior to its acquisition by Teleflex Inc. (NYSE:TFX). Cancer company Partner Therapeutics...
...S.A. ADC Therapeutics S.A. Relay Therapeutics Inc. Biodesix Inc. Odylia Therapeutics Inc. Kaleido Biosciences Inc. CorMedix Inc. T1D Exchange Neurana Pharmaceuticals Inc. Assembly Biosciences Inc. Partner Therapeutics Inc. Teva...

...company ImCheck Therapeutics S.A.S. (Marseille, France) appointed Debasish Roychowdhury as chairman. He is CMO at Partner Therapeutics Inc....

...He was SVP and head of early clinical development at Pfizer Inc. (NYSE:PFE). Cancer company Partner Therapeutics Inc....

...Newco Partner Therapeutics Inc. (Boston, Mass.) raised $60 million on Thursday in a series A round led by...
...to use this initial financing to acquire a cancer-focused portfolio of approved and late-stage therapies. Partner Therapeutics'...
...Partner Therapeutics gained exclusive, worldwide rights to develop, manufacture and commercialize cancer drug Leukine from Sanofi. Partner Therapeutics...

...Newco Partner Therapeutics Inc. (Boston, Mass.) raised $60 million on Feb. 1 in a series A round led...
...Partner Therapeutics gained exclusive, worldwide rights to develop, manufacture and commercialize cancer drug Leukine from Sanofi. Partner Therapeutics...
...a March 29 PDUFA date. Partner Therapeutics Inc., Boston, Mass. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Cancer Jennie Walters Partner Therapeutics Inc.SanofiRocheSeragonMerrimack...

...Robert Mulroy and Debasish Roychowdhury launched newco Partner Therapeutics Inc. (Boston, Mass.), which has a portfolio of approved...